The global isothermal nucleic acid amplification technology market reached a value of US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2027, exhibiting a CAGR of 12.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The isothermal nucleic acid amplification technology (INAAT) is used in the field of molecular biology and recombinant DNA technologies for detecting and analyzing nucleic acids. This technique is commonly used for DNA, RNA, cells, proteins, small molecules and ions to ensure the rapid, sensitive and accurate diagnosis of infectious, genetic and inherited diseases. The amplicons generated from this technique are used for producing versatile nucleic acid nanomaterials that are widely utilized in biomedicine, bioimaging and biosensing. They are also used for the detection of various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia and gonorrhea (CT/NG).

One of the leading trends in the global market is the ongoing development of INAAT for the detection of the coronavirus disease (COVID-19), as it can be conducted at room temperature, without the need for specialized laboratory equipment. Furthermore, the increasing prevalence of cancer and other chronic medical ailments, along with the rising demand for efficient diagnosis and treatment alternatives, is also providing a boost to the market growth. In line with this, the widespread adoption of Loop-mediated Isothermal Amplification (LAMP) tests that are used for the amplification of both DNA and RNA, along with the identification of genetically modified organisms (GMOs) is driving the product demand further. Additionally, various technological advancements, such as the development of Strand Displacement Amplification (SDA), Single Primer Isothermal Amplification (SPIA) and Recombinase Polymerase Amplification (RPA), is acting as another growth-inducing factor. Other factors, including the rising geriatric population across the globe, coupled with extensive research and development (R&D) activities in the field of microbiology and significant growth in the healthcare infrastructure, are projected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end-user.

Breakup by Product:

Instruments
Reagents

Breakup by Technology:

Helicase-Dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-Mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-Based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others

Breakup by Application:

Infectious Disease Diagnosis
Hepatitis
CT/NG
HIV
Influenza
Others
Blood Screening
Others

Breakup by End-User:

Hospitals
Diagnostic Laboratories
Research Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, bioM?rieux, BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG and Ustar Biotechnologies Ltd., etc. Key Questions Answered in This Report:

How has the global isothermal nucleic acid amplification technology market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global isothermal nucleic acid amplification technology market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global isothermal nucleic acid amplification technology market and who are the key players?
What is the degree of competition in the industry?